Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0XG3Y
|
|||
Former ID |
DNCL002976
|
|||
Drug Name |
TZP-102
|
|||
Indication | Diabetic gastroparesis [ICD-11: DA41.00] | Phase 2 | [1] | |
Company |
Tranzyme Pharma
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01664637) Diabetic Gastroparesis Efficacy/Safety Study of TZP-102. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.